Amneal Pharmaceuticals, Inc.
AMRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$73,876 | -$48,722 | -$254,789 | $10,624 |
| Dep. & Amort. | $236,191 | $229,400 | $240,175 | $233,406 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $27,768 | $26,822 | $31,847 | $0 |
| Change in WC | -$4,068 | -$47,186 | -$59,945 | -$133,593 |
| Other Non-Cash | $109,084 | $185,263 | $107,812 | $131,383 |
| Operating Cash Flow | $295,099 | $345,577 | $65,100 | $241,820 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$60,340 | -$46,801 | -$48,795 | -$49,428 |
| Net Acquisitions | $11,994 | $0 | -$84,714 | -$141,543 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$14,650 | -$22,388 | -$40,800 | -$3,211 |
| Investing Cash Flow | -$62,996 | -$69,189 | -$174,309 | -$194,182 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$185,118 | $22,652 | -$38,272 | -$79,179 |
| Stock Issued | $0 | $0 | $0 | $853 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$26,673 | -$235,225 | -$68,348 | -$59,796 |
| Financing Cash Flow | -$211,791 | -$212,573 | -$106,620 | -$138,122 |
| Forex Effect | -$999 | $65 | -$5,683 | $102 |
| Net Chg. in Cash | $19,313 | $63,880 | -$221,512 | -$90,382 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $99,107 | $35,227 | $256,739 | $347,121 |
| End Cash | $118,420 | $99,107 | $35,227 | $256,739 |
| Free Cash Flow | $220,109 | $276,388 | -$25,495 | $194,092 |